López CL, Proaño J, Ambrosio J, Ávila RG, Flisser A

Language: Spanish
References: 21
Page: 164-167
PDF size: 38.51 Kb.

ABSTRACT

Cysticercosis is the most frequent parasitic disease of the central nervous system. The main risk factor for acquiring neurocysticercosis (NCC) is the presence of a carrier of the adult stage of Taenia solium in the household, who usually is asymptomatic, although he can recognise proglottids in the feces. With the purpose of identifying such carriers, patients with NCC that attended the Service of Neurology at the National Medical Centre XXI Century and their families were studied. Taeniosis cases from the National Institute of Paediatrics, as well as those reported by State Public Health Laboratories of Mexico and Tlaxcala were also included in the study. Clinical aspects of the patients with NCC and taeniosis were analyzed. Clinical manifestations of NCC found were similar to those described in the literature. Headache, hyperorexia, pain in the right hypochondrium and constipation were present with statistical significance in patients with taeniosis. The technical difficulty for the diagnosis of taeniosis and for the obtention of the parasite after treatment were notorious, as well as the lack of information regarding the disease by the patients with taeniosis and their families.

REFERENCES

1. Flisser A, Madrazo I, Delgado H. Cisticercosis humana. ISBN 968-4267398, El Manual Moderno, 1998: 171.

2. Sotelo J, del Brutto OH. Brain cysticercosis. Review article. Arch Med Res 2000; 31: 3-14.

3. Schenone H, Villaroel F, Rojas A, Ramírez R. Epidemiology of human cysticercosis in Latin America. In: A Flisser, K Willms, JP Laclette, C Larralde, C Ridaura, F Beltrán (eds). Cysticercosis. Present State of Knowledge and Perspectives. ISBN 0-12-260740-6. Academic Press, New York, 1982: 25-38.

4. Velasco Suarez M, Bravo Becherelle MA, Quirasco F. Human cysticercosis: medical-social implications and economic impact. En A Flisser, K Willms, JP Laclette, C Larralde, C Ridaura, F Beltrán (eds). Cysticercosis. Present State of Knowledge and Perspectives. ISBN 0-12-260740-6. Academic Press, New York, 1982: 25-38.

5. Sarti E, Schantz P, Plancarte A, Wilson M, Gutierrez I, López A, Roberts J, Flisser A. Prevalence and risk factors for Taenia solium taeniosis and cysticercosis in humans and pigs in a village in Morelos, Mexico. Am J Trop Med Hyg 1992; 46: 677-684.

6. Díaz S, Candil R, Uribe M, Willms K. Serology as an indicator of Taenia solium tapeworm infections in a rural community in Mexico. Trans Royal Soc Trop Med Hyg 1990; 84: 563-566.

7. Tay J, Salazar PM, Haro I, Bucio MI. Frecuencia de las helmintiasis intestinales en México. Rev Invest Salud Públ 1976; 36: 241-280.

8. Sarti E, Schantz PM, Avila G, Ambrosio J, Medina-Santillán R, Flisser A. Mass treatment against human taeniasis for the control of cysticercosis: a population-based intervention study. Transact Royal Soc Trop Med Hyg 2000; 94: 85-89.

9. Sarti E, Schantz PM, Lara-Aguilera R, Gómez-Dantés H, Flisser A. Taenia solium taeniasis and cysticercosis in a Mexican village. Trop Med Parasitol 1988; 39: 194-198.

10. Sarti E, Flisser A, Schantz PM, Gleizer M, Loya M, Plancarte A, Avila G, Allan J, Craig PS, Bronfman M, Wijeyaratne P. Development and evaluation of health education intervention against Taenia solium in a rural community in Mexico. Am J Trop Med Hyg 1997; 56: 127-32.

11. Schantz P, Moore A, Muñoz J, Hartman B, Shaefer J, Aron A, Persaud D, Sarti E, Gracos A, Flisser A. Neurocysticercosis in an orthodox Jewish community in New York City. New England J Med 1992; 327: 692-695.

12. García-García ML, Torres M, Correa D, Flisser A, Sosa-Lechuga A, Velasco O, Meza-Lucas A, Plancarte A, Avila G, Tapia R, Aguilar L, Mandujano A, Alcántara I, Morales Z, Salcedo A, Manon ML, Valdespino JL. Prevalence and risk of cysticercosis and taeniasis in an urban population of soldiers and their relatives. Am J Trop Med Hyg 2000; 61: 386-389.

13. Allan JC, Avila G, García Noval J, Flisser A. Immunodiagnosis of taeniosis by coproantigen detection Parasitology 1991; 101: 473-7.

14. Tsang V, Brand A, Boyer A. An enzyme linked immunoelectrotransfer blot assay by glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J Infect Dis 1989; 159: 50-59.

15. Flisser A. Taenia solium, Taenia saginata and Hymenolepis nana. In: MJG Farthing, GT Keusch, D Wakelin (eds), Enteric Infection 2. Intestinal Helminths. ISBN 0-412-39140-6. Chapman & Hall Medical, London, 1995: 173-189.

16. Pawlowski ZS, Schultz MG. Taeniasis and Cysticercosis. Advances in Parasitology 1972; 10: 269-343.

17. Wilson M, Bryan RT, Fried JA, Ware DA, Schantz PM, Pilcher JB, Tsang VCW. Clinical evaluation of the cysticercosis enzyme linked immunoelectrotransfer blot in patients with neurocysticercosis. J Infect Dis 1991; 164: 1007-1009.

18. Sanchez AL, Medina MT, Ljungström I. Prevalence of taeniasis and cysticercosis in a population of urban residence in Honduras. Acta Tropica 1998; 69: 141-149.

19. Perera D, Western KA, Schultz MG. Niclosamide treatment of cestodiasis. American Journal of Tropical Medicine Hygiene 1970; 19: 610-612.

20. Allan J, Velásquez-Tohom M, Torres-Alvarez R, Yurrita P, García Noval J. Field trial of the coproantigen-based diagnosis of Taenia solium taeniasis by enzyme- linked immunosorbent assay. Am J Trop Med Hyg 1996; 54:352–356.

21. Keilbach N, Aluja A, Sarti E. A programme to control taeniosis and cysticercosis (Taenia solium). Experiences in a Mexican village. Acta Leidensia 1989; 57: 181-189.